Powered by Lexis+® UK
Jurisdiction(s):
United Kingdom
Glossary
CASE STUDY

“I'm able to do more in the day, which means I'm providing more value to my clients - and it's helped my margins in terms of how much I can bill. LexisNexis is helping me make money.”

ParrisWhittaker

Access all documents on CRL

CRL meaning

Published by a LexisNexis Energy expert
What does CRL mean?
In legal practice, CRL refers to Chalk River Laboratories, the nuclear research and development site at Chalk River, Ontario, Canada. It is a major facility supporting and advancing nuclear technology, particularly candu reactor technology. The term is descriptive and not defined in UK or Irish legislation or case law. It commonly appears in nuclear procurement and supply contracts, R&D collaboration agreements, testing/irradiation service agreements, intellectual property licences, technical schedules, and due diligence. Typical legal issues include export control and sanctions compliance (for example, the UK Export Control Order 2008 and UK/EU dual‑use and nuclear goods controls), transport of radioactive materials, nuclear safeguards, liability and indemnity allocation, data/security clearances, and confidentiality of sensitive information. For drafting certainty, identify the relevant legal entity (Canadian Nuclear Laboratories as operator, or Atomic Energy of Canada Limited as owner), the precise facility to be used within the CRL site, governing law and jurisdiction, and any required permits or approvals (including Canadian Nuclear Safety Commission requirements). Usage of CRL is broadly consistent across England & Wales, Scotland, Northern Ireland and Ireland, with Canadian law governing on‑site activities and domestic regulatory obligations applying to UK/Irish parties engaged in cross‑border work with CRL.
Speed up all aspects of your legal work with tools that help you to work faster and smarter. Win cases, close deals and grow your business–all whilst saving time and reducing risk.

View the related News about CRL

NEWS
PI and Clinical Negligence update (England and Wales): AI in rehabilitation, FRC and whiplash reviews, anonymity orders, key case law, NAO costs report, judiciary AI guidance, LSB/CRL regulatory changes

In this issue: Key PI and Clinical Negligence developments Road traffic accidents Public authorities and the state Clinical negligence Other PI and Clinical Negligence news LexTalk®PI & Clinical Negligence: a Lexis®Nexis community Daily and weekly news alerts LexisNexis® Webinars Useful information Key PI and Clinical Negligence developments AI in personal injury rehabilitation Artificial Intelligence (AI) is swiftly reshaping countless parts of contemporary life, advancing faster than most anticipated. Yet in personal injury, one thing endures: rehabilitation’s impact. For claimants, it offers a route to maximise potential and pursue the greatest independence and quality of life achievable. For defendants, it may lessen dependency and consequently diminish a claim’s overall worth. Against this backdrop, considering ways AI could augment—rather than supplant—the rehabilitation pathway is both opportune and vital. Authored by Pamela-Jane Riley, legal director in the Catastrophic Injury and Large Loss Team, and Nicola Perrott, senior associate in the Healthcare team at Clyde...

Read More Right Arrow
NEWS
SRA approves plan to regulate CILEX, pending CILEX decision and LSB approval; Law Society opposes; CRL considers legal challenge (England and Wales)

SRA board clears plan to regulate CILEX members On 1 July 2024, the SRA announced its board had approved proposals to oversee Chartered Institute of Legal Executives (CILEX) members, following more than two years of talks and negotiation. The move is not final, though. In a statement issued the same day, the SRA explained that, should CILEX choose to proceed, any redelegation would still require sign‑off from the Legal Services Board. The board’s resolution could mark the culmination of a process set in motion in January 2022, when CILEX first asked the SRA to take over from its own dedicated regulator, CILEX Regulation Ltd (CRL). Since then, at least four separate consultations have been carried out and the LSB has undertaken an investigation. In reflecting on the change since CILEX approached the SRA, Anna Bradley, the SRA’s chair, said the regulator has thought 'long and hard' about the potential risks and benefits. It still requires LSB approval in order to proceed...

Read More Right Arrow

View the related Practice Notes about CRL

PRACTICE NOTES
CJEU: Standalone exchanges of confidential, strategic pricing information (including future credit spreads) can be restrictions by object under Article 101 TFEU — Case C‑298/22 (banking)

CASE HUB ARCHIVED This archived case hub sets out the position as at the judgment dated 29 July 2024; it is no longer updated. For more, see the timeline Case facts Outline A reference from Portugal asks for guidance on how Article 101 TFEU should be interpreted regarding certain exchanges of information. Latest developments On 29 July 2024, the Court of Justice held that a solitary exchange of confidential data between rivals can amount to a restriction by object. That applies where the information is confidential and strategic, as it can disclose a competitor’s intended future conduct on the relevant market. Parties Applicants: Banco BPN/BIC Português, SA, Banco Bilbao Vizcaya Argentaria SA, Portuguese branch, Banco Português de Investimento SA (BPI), Banco Espírito Santo SA (in liquidation), Banco Santander Totta SA, Barclays Bank Plc, Caixa Económica Montepio Geral – Caixa Económica Bancária, SA, Caixa Geral de Depósitos, SA, Unión de Creditos Imobiliarios, SA – Estabelecimento Financeiro de Crédito SOC, Caixa Central...

Read More Right Arrow